Vascularized Composite Allograft Program Security Risk Assessment Checklist
A VCA program handles sensitive information across evaluation, allocation, procurement, surgery, and long-term follow-up. Use this checklist to identify where information could be exposed, altered, lost, or made unavailable, then document the controls, owners, and corrective actions for each risk.
For organizations covered by the HIPAA Security Rule, risk analysis must assess potential risks and vulnerabilities to the confidentiality, integrity, and availability of electronic protected health information (ePHI). The HIPAA Security Rule and HHS Office for Civil Rights risk-analysis guidance are useful starting points. Tailor the assessment to your program’s systems, partners, workflows, and applicable requirements.
What risks should a VCA program security assessment cover?
Start by mapping where VCA information is created, received, stored, used, and disclosed. Include electronic health records, transplant and donor databases, imaging and laboratory systems, paper files, email, messaging, mobile devices, backups, and information exchanged with organ procurement organizations (OPOs), laboratories, transport providers, and other partners.
- Confidentiality: Could someone view or share donor, candidate, recipient, or family information without authorization?
- Integrity: Could clinical findings, allocation records, consent documents, or follow-up data be changed, lost, or entered incorrectly?
- Availability: Could a cyberattack, system outage, facility disruption, or unavailable vendor prevent staff from accessing information needed for time-sensitive care?
- Third-party exposure: Do vendors and partner organizations receive only the information they need, under appropriate agreements and secure transfer procedures?
- Human and physical risks: Could misdirected messages, shared accounts, unattended screens, lost devices, or improperly disposed paper records expose information?
For each scenario, record the affected information and systems, likely threats and vulnerabilities, potential impact, existing safeguards, remaining risk, accountable owner, and planned remediation. Review role-based access, user provisioning and removal, audit-log review, incident response, backups and recovery, workforce training, and physical protections. HIPAA’s specific safeguards depend on the organization and circumstances; document the decisions and alternative measures where applicable rather than treating every technical control as universally prescribed.
How should allocation, procurement, distribution, and transplantation workflows be secured?
Trace the information and approvals that support each handoff, from referral and candidate registration through offer, recovery, transport, receipt, and transplantation. The OPTN notices of implemented actions identify implemented VCA policy changes; confirm the current OPTN requirements and program-specific procedures when conducting the assessment.
- Allocation: Restrict access to candidate and donor records, waiting-list data, offer communications, and allocation documentation to authorized staff. Preserve records showing decisions, approvals, and relevant communications in accordance with the applicable VCA allocation policy and OPTN requirements.
- Authorization and procurement: Verify that the required VCA authorization and procurement documentation are recorded, attributable to the appropriate donor or decision-maker, and available to staff who need them. HRSA’s guidance on deceased donor VCA authorization states that VCA recovery for transplant must be specifically authorized and documented.
- Distribution and transport: Use approved communication channels for donor and graft details. Define how staff verify recipient identity, graft labels, transport status, receipt, and any changes or delays; keep a traceable record of handoffs.
- Surgery: Limit access to operative plans and records, including the procurement and reconstruction surgical assessment, to the relevant care and recovery teams. Document approvals and changes to the plan.
- Downtime: Establish secure procedures for allocation and clinical coordination during system outages, including later reconciliation of records and access to essential information.
How can living donor consent and confidentiality be protected?
Separate donor and recipient workflows where practical, and restrict access to a living donor’s evaluation, decision-making, and withdrawal information. The OPTN’s living VCA donor guidance provides recommendations on informed consent, evaluation, confidentiality, and donor protections. It also explains that VCA-specific living donor protections have not all been established as OPTN policy; programs should distinguish applicable requirements from guidance and institutionally adopted procedures.
- Provide a confidential way for a donor to pause or leave the process, and make sure the donor knows they may decline at any time.
- Identify an independent living donor advocate (ILDA) who supports the donor’s interests and is not involved in the recipient’s evaluation or transplant decision.
- Limit disclosure of donor workup and decision-making information to the recipient team unless the donor has consented to that sharing. HRSA’s donor and recipient information-sharing guidance recommends controlled, private exchanges and confidential opt-out procedures.
- Record consent versions, interpreter support when used, permissions for information sharing, and who accessed or disclosed donor information.
- Train staff not to reveal a donor’s withdrawal or reasons for withdrawing to the recipient or others without appropriate authorization.
These safeguards can help a potential donor decline privately without being pressured to give an explanation to the recipient. HRSA also describes the independent advocate’s role in protecting donor interests and supporting a donor who decides to stop the process in its living donation FAQs.
What medical and surgical evaluation records require safeguards?
Include records for both donors and recipients, and identify who needs access at each stage. VCA files may contain especially sensitive information because evaluation and follow-up can involve medical, functional, psychosocial, and reconstructive details.
- Donor evaluation: Consent and psychosocial assessments, medical history, examination results, imaging, laboratory findings, blood type and compatibility information, and transmissible disease screening results.
- Recipient evaluation: Eligibility assessments, relevant medical and psychosocial records, compatibility information, and documentation supporting the proposed transplant and alternatives.
- Procedure planning: Procurement and reconstruction surgical assessment, operative plans, anesthesia information, graft identification, and recovery or transport documentation.
- Care and follow-up: Medication and immunosuppression records, complications, rejection assessments, additional procedures, functional outcomes, and other follow-up information needed for care and reporting.
Use access controls that reflect each person’s role, review access when responsibilities change, and protect sensitive records in exports, reports, meetings, and research workflows. Define how corrections are made so that authorized changes remain traceable and clinical teams can distinguish current information from superseded records.
Ready to assess your HIPAA security risks?
Join thousands of organizations that use Accountable to identify and fix their security gaps.
Take the Free Risk AssessmentHow should transplant and follow-up data be protected and monitored?
Set clear rules for which data the program collects, who validates it, how it is submitted, and how long records are retained. OPTN VCA recipient registration and follow-up data collection includes information tailored to VCA type; examples in the OPTN VCA outcomes data-collection notice include functional measures for upper-limb recipients and VCA-specific follow-up information.
- Assign a responsible data steward and a clinical reviewer for each required dataset.
- Use validation checks for missing, inconsistent, or implausible entries, and record how corrections are authorized.
- Restrict identifiable data to authorized users; use de-identified or limited datasets for secondary analysis when appropriate.
- Monitor access logs and investigate unusual access, bulk downloads, failed logins, and unexpected changes to transplant records.
- Reconcile submitted transplant outcome data with the clinical record and retain evidence of submission and correction workflows.
Effective transplant outcome data governance supports both patient safety and trustworthy reporting. The OPTN data notice describes data collection intended to improve outcome assessment and emphasizes that staff must know where required data are found in medical records.
What controls support program oversight and inactivation notifications?
Connect security responsibilities with transplant program governance. Maintain an inventory of key personnel, credentials, program approvals, required protocols, delegated responsibilities, and the systems used to document compliance with transplant program membership requirements. HRSA’s implemented-action records identify VCA membership and inactivation-related changes; the program should use current governing materials when confirming its obligations.
- Assign owners for security risk review, access approvals, policy maintenance, incident escalation, and corrective actions.
- Review access when staff join, change roles, leave, or begin work with a different VCA type.
- Keep evidence of staff training, system reviews, risk decisions, incidents, and follow-up actions.
- Maintain an incident response plan that coordinates privacy, security, clinical operations, and required external reporting.
- Document how the program will maintain essential patient communications and records during a disruption or inactivation.
OPTN’s implemented notice for VCA program inactivation states that programs must follow applicable Appendix K provisions, including candidate communications for relevant inactivation or cessation scenarios. Check the VCA program inactivation notice and current bylaws for details, then make sure notification responsibilities, contact lists, and documentation steps are included in your continuity procedures.
What limitations should programs address in a security risk assessment?
A checklist helps organize the review, but it does not establish that a program is compliant or eliminate risk. The assessment must reflect the program’s actual systems, workflows, contracts, workforce, and VCA types. Reassess when those conditions change, after significant incidents, and when reviews identify new risks.
Also distinguish binding requirements from OPTN guidance, institutional policy, and recommended security practices. HIPAA applies to covered entities and business associates as defined by law; not every organization participating in a VCA workflow has the same HIPAA status. Confirm applicable federal, state, contractual, research, and OPTN obligations with qualified compliance and privacy personnel. Treat this checklist as a planning aid, not legal advice or proof of organizational compliance.
In summary, a useful VCA security risk assessment follows sensitive information through its full lifecycle, protects donor and recipient confidentiality, secures clinical and allocation workflows, and assigns accountable owners to monitoring and continuity tasks.
FAQs.
What should a VCA program security risk assessment include?
It should identify the information and systems used across donor and recipient evaluation, allocation, procurement, surgery, and follow-up; assess confidentiality, integrity, and availability risks; review access, vendors, physical safeguards, incident response, and recovery plans; and document owners, decisions, and remediation. Applicable HIPAA and OPTN requirements depend on the organization and current program obligations.
How can a living donor decline the process confidentially?
Give the donor a private, direct way to tell the donor coordinator, social worker, or ILDA that they wish to stop. Explain that they may withdraw at any time, restrict access to the decision and evaluation details, and do not share those details with the recipient team without the donor’s consent, consistent with applicable requirements and program procedures.
Who supports a living donor during evaluation?
An independent living donor advocate supports the donor’s interests and helps the donor understand the process, risks, and right to stop. The OPTN’s VCA-specific living donor guidance recommends that the advocate be independent of the recipient evaluation and transplant decision; programs should confirm which requirements apply to their circumstances.
What VCA data should be collected for patient safety?
Collect the data required by applicable OPTN reporting and clinical protocols, along with information needed to monitor the recipient’s graft, complications, treatment, functional outcomes, and follow-up. Data needs vary by VCA type. Use the current OPTN forms and definitions, validate submissions against the medical record, and limit identifiable data access to authorized users.
Table of Contents
- What risks should a VCA program security assessment cover?
- How should allocation, procurement, distribution, and transplantation workflows be secured?
- How can living donor consent and confidentiality be protected?
- What medical and surgical evaluation records require safeguards?
- How should transplant and follow-up data be protected and monitored?
- What controls support program oversight and inactivation notifications?
- What limitations should programs address in a security risk assessment?
- FAQs.
Ready to assess your HIPAA security risks?
Join thousands of organizations that use Accountable to identify and fix their security gaps.
Take the Free Risk Assessment